Notice of NIAMS' Participation in PAR-23-109, "NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)"
Notice Number:
NOT-AR-23-023

Key Dates

Release Date:

September 7, 2023

Related Announcements

  •  March 10, 2023 - NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed). See PAR-23-109.

Issued by

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will participate in PAR-23-109,  "NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)" effective for the August 8, 2024 due date and subsequent due dates. The following changes and updates have been made to PAR-23-109 (shown in bold italics) to reflect NIAMS' participation in this NOFO.

Part 1. Overview Information

Components of Participating Organizations

National Institute of Allergy and Infectious Diseases (NIAID)
National Cancer Institute (NCI)
National Eye Institute (NEI)
National Heart, Lung, and Blood Institute (NHLBI)
National Human Genome Research Institute (NHGRI)
National Institute on Aging (NIA)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Neurological Disorders and Stroke (NINDS)
National Center for Advancing Translational Sciences (NCATS)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)


Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.855, 93.398, 93.867, 93.838, 93.837, 93.839, 93.840, 93.233, 93.172, 93.866, 93.173, 93.279, 93.113, 93.350, 93.121, 93.853, 93.846

Scientific/Research Contact(s)

Marie Mancini, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-5032 
Email: mancinim2@mail.nih.gov


Financial/Grants Management Contact(s)


Erik Edgerton
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Tel:  (301) 594-7760
Email:  edgertont@mail.nih.gov 



 All other aspects of the NOFO remain the same.



 

Inquiries

Please direct all inquiries to:

Marie Mancini, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-5032 
Email: mancinim2@mail.nih.gov